Alphatec Holdings reported second quarter financial results for the period ended June 30, 2026, showing total revenue of $214 million, a 15% year-over-year increase. Surgical revenue reached $196 million, up 17%, driven by 20% case volume growth and a 24% increase in net new surgeon users. The company reported GAAP net loss of $26 million but achieved Non-GAAP net income of $11 million and adjusted EBITDA of $36 million. Alphatec reaffirmed its full-year 2026 revenue outlook of approximately $882 million while increasing its adjusted EBITDA guidance to approximately $140 million from the prior expectation of $134 million, citing improved operating leverage. The company also expects at least $20 million in free cash flow for the fiscal year. Alphatec Holdings operates in the medical device industry, specializing in innovative spine surgery solutions and technologies.